The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Open accessAbstract
Purpose: Chronic inflammation is believed to contribute to the development and progression of breast cancer. Systemic C-reactive protein (CRP) and serum amyloid A (SAA) are measures of low-grade chronic inflammation and potential predictors of cancer survival. Patients and Methods: We evaluated the relationship between circulating markers of inflammation and breast cancer survival using data from the Health, Eating, Activity, and Lifestyle (HEAL) Study (a multiethnic prospective cohort study of women diagnosed with stage 0 to IIIA breast cancer). Circulating concentrations of CRP and SAA were measured approximately 31 months after diagnosis and tested for associations with disease-free survival (approximately 4.1 years of follow-up) and overall survival (approximately 6.9 years of follow-up) in 734 disease-free breast cancer survivors. Cox proportional hazards models were used with adjustment for potential confounding factors to generate hazard ratios (HRs) and 95% CIs. Results: Elevated SAA and CRP were associated with reduced overall survival, regardless of adjustment for age, tumor stage, race, and body mass index (SAA P trend < .0001; CRP P trend = .002). The HRs for SAA and CRP tertiles suggested a threshold effect on survival, rather than a dose-response relationship (highest v lowest tertile: SAA HR = 3.15; 95% CI, 1.73 to 5.65; CRP HR = 2.27; 95% CI, 1.27 to 4.08). Associations were similar and still significant after adjusting for self-reported history of cardiovascular events and censoring cardiovascular disease deaths. Elevated CRP and SAA were also associated with reduced disease-free survival, although these associations were of borderline significance (SAA P trend = .04; CRP P trend = .07). Conclusion: Circulating SAA and CRP may be important prognostic markers for long-term survival in breast cancer patients, independent of race, tumor stage, and body mass index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Serum amyloid A, the major vertebrate acute‐phase reactant
Uhlar, C. M., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,106
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
Hooning, M. J., Botma, A., Aleman, B. M. P., Baaijens, M. H. A., Bartelink, H., Klijn, J. G. M., Taylor, C. W., & van Leeuwen, F. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk064 · Cited by 861
DeNardo, D. G., & Coussens, L. M. (2007) · Breast Cancer Research · doi:10.1186/bcr1746 · Cited by 677
Irwin, M. L., Crumley, D., McTiernan, A., Bernstein, L., Baumgartner, R., Gilliland, F. D., Kriska, A., & Ballard‐Barbash, R. (2003) · Cancer · doi:10.1002/cncr.11227 · Cited by 611
Self-citationNon-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Self-citationSystemic inflammatory response predicts survival following curative resection of colorectal cancer
McMillan, D. C., Canna, K., & McArdle, C. S. (2003) · British Journal of Surgery · doi:10.1002/bjs.4038 · Cited by 454
Physical activity levels among breast cancer survivors.
Irwin, M. L., McTiernan, A., Bernstein, L., Gilliland, F. D., Baumgartner, R., Baumgartner, K. B., & Ballard-Barbash, R. R. (2004) · PubMed · Cited by 354
Self-citationEvaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer
Ramsey, S., Lamb, G. W. A., Aitchison, M., Graham, J., & McMillan, D. C. (2007) · Cancer · doi:10.1002/cncr.22400 · Cited by 334
Scott, H. R., McMillan, D. C., Forrest, L. M., Brown, D. J. F., McArdle, C. S., & Milroy, R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600466 · Cited by 322
Schultz, D. R., & Arnold, P. I. (1990) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(90)90055-k · Cited by 293
Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors
McTiernan, A., Rajan, K. B., Tworoger, S. S., Irwin, M., Bernstein, L., Baumgartner, R., Gilliland, F., Stanczyk, F. Z., Yasui, Y., & Ballard-Barbash, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.057 · Cited by 278
Self-citationEvaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
Murri, A. M. A., Bartlett, J. M. S., Canney, P. A., Doughty, J. C., Wilson, C., & McMillan, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602922 · Cited by 211
Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness
Yamada, T. (1999) · cclm · doi:10.1515/cclm.1999.063 · Cited by 195
Crumley, A. B. C., McMillan, D. C., McKernan, M., Going, J. J., Shearer, C. J., & Stuart, R. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603150 · Cited by 161
Pierce, B. L., Neuhouser, M. L., Wener, M. H., Bernstein, L., Baumgartner, R., Ballard-Barbash, R. R., Gilliland, F. D., Baumgartner, K. B., Sorensen, B. E., McTiernan, A., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9985-5 · Cited by 115
Self-citationWong, V., Malik, H. M. A., Hamady, Z. Z. R., Al-Mukhtar, A., Gomez, D., Prasad, R. K., Toogood, G. J., & Lodge, J. P. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603558 · Cited by 113
Evaluation of Serum Amyloid A as a Biomarker for Gastric Cancer
Chan, D., Chen, C., Chu, H.-C., Chang, W., Yu, J., Chen, Y., Wen, L., Huang, S.-C., Ku, C., Liu, Y., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9091-z · Cited by 109
Murri, A. M. A., Wilson, C., Lannigan, A., Doughty, J., Angerson, W. J., McArdle, C. S., & McMillan, D. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603682 · Cited by 79
Rapid recycling of cholesterol: The joint biologic role of C-reactive protein and serum amyloid A
Manley, P. N., Ancsin, J. B., & Kisilevsky, R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.10.018 · Cited by 66
Albuquerque, K., Price, M. R., BADLEY, R. A., Jönrup, I., Pearson, D., Blamey, R. W., & Robertson, J. F. R. (1995) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(95)96935-7 · Cited by 64
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
Cited by
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Küttner, V., et al. (2018) · Science · doi:10.1126/science.aao4227 · Cited by 1,476
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
Why Sleep Is Important for Health: A Psychoneuroimmunology Perspective
Irwin, M. R. (2015) · Annual Review of Psychology · doi:10.1146/annurev-psych-010213-115205 · Cited by 1,325
“In addition, inflammation appears to be a prognostic factor predicting breast cancer recurrence (Cole 2009, Pierce et al. 2009).”
BackgroundChan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Self-citationReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
Metadata
- Authors
- Pierce, B. L., Ballard-Barbash, R., Bernstein, L., Baumgartner, R. N., Neuhouser, M. L., Wener, M. H., Baumgartner, K. B., Gilliland, F. D., Sorensen, B. E., McTiernan, A., & Ulrich, C. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-07-20
- Volume
- 27
- Issue
- 21
- Pages
- 3437-3444
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2167409896
- Cited by
- 691
- References
- 22
- FWCI
- 20.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.